NewsPR Newswire
Virax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland China
· Published
Article summary
Three new distributor agreements build on initial China sales and extend the Company's distributor-led commercial strategy LONDON, Oct. 29, 2026 — Virax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that, through its China subsidiary,...
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…